Celgene Corp - Company Profile

Powered by

All the data and insights you need on Celgene Corp in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Celgene Corp Strategy Report

  • Understand Celgene Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Celgene Corp: Overview

Select Item

Celgene Corp (Celgene), a subsidiary of Bristol-Myers Squibb Co, is an integrated biopharmaceutical company that discovers, develops, manufactures, and markets novel gene and protein regulation therapies for the treatment of cancer and immune-inflammatory diseases. Its major product portfolio includes Revlimid (lenalidomide), Pomalyst (pomalidomide) and Thalomid (thalidomide) for the treatment of multiple myeloma; and Abraxane (paclitaxel albumin-bound particles for injectable suspension) for various types of cancers, among others. The company sells its products through own sales organizations and distributors in Europe, the Middle-East, the Americas, and Asia-Pacific. Celgene is headquartered in Summit, New Jersey, the US.

 Gain a 360-degree view of Celgene Corp and make more informed decisions for your business Gain a 360-degree view of Celgene Corp and make more informed decisions for your business Find out more
Headquarters United States of America
Address 86 Morris Avenue, Summit, New Jersey, 07901
Website www.celgene.com
Telephone 1 800 3844907
Industry Pharmaceuticals and Healthcare
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Celgene Corp premium industry data and analytics

1,300+

Clinical Trials

Determine Celgene Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

500+

Catalyst Calendar

Proactively evaluate Celgene Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

400+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Celgene Corp’s relevant decision makers and contact details.

360+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

240+

Pipeline Drugs

Identify which of Celgene Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

50+

Marketed Drugs

Understand Celgene Corp’s commercialized product portfolio to stay one step ahead of the market.

14+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Celgene Corp and assess market opportunity for new entrants with patient population 8-year forecasts.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Celgene Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Marketed Vidaza
Paclitaxel Protein-Bound Particles For Injectable Suspension (Albumin-Bound) Abraxane
Thalidomide Istodax
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Celgene Corp portfolio and identify potential areas for collaboration Understand Celgene Corp portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Celgene Corp Johnson & Johnson Merck & Co Inc Sanofi Novartis AG
Headquarters United States of America United States of America United States of America France Switzerland
City Summit New Brunswick Kenilworth Paris Basel
State/Province New Jersey New Jersey New Jersey Ile-de-France -
No. of Employees - 131,900 72,000 87,994 76,057
Entity Type Private Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Celgene Corp key executives to enhance your sales strategy Gain insight into Celgene Corp key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward